HOME >> BIOLOGY >> NEWS
Mutation may help cause acute myeloid leukemia

ed to inhibit aml1-eto and tyrosine kinase receptors might one day be used to control this disease."

Tyrosine kinases power chemical reactions in cells, particularly those involved in cell division. Normally, these molecules are carefully regulated to keep a tight lid on cell growth. But they can lose that regulation when tyrosine kinase genes mutate. Instead of powering reactions only when appropriate, for example, the tel-pdgfrb protein runs constantly, like an engine that won't shut off.

"Mutations in tyrosine kinases can push cells to divide," says Grisolano. "If this is combined with a mutation that blocks cells from maturing, as does the aml1-eto gene, it can lead to cancer."

For example, mutations in a gene known as flt3 (pronounced flit 3), also in the tyrosine-kinase gene family, are among the most common mutations in people with AML. Drugs that block flt3 are being developed as a possible treatment for AML. Tel-pdgfrb is closely related to flt3.

"This study further supports the idea that tyrosine kinases may be highly worthwhile targets for new drugs to treat AML," says Tomasson.


'"/>

Contact: Darrell E. Ward
wardd@msnotes.wustl.edu
314-286-0122
Washington University School of Medicine
1-Aug-2003


Page: 1 2

Related biology news :

1. Mutation causes specific arrhythmia and sudden cardiac death
2. Mutation in DKC1 gene can cause rare aging disease and cancer
3. Mutations may yield clues to heartbreaking childhood disease
4. Mutations in the ABCR gene are an overwhelming cause of inherited vision loss
5. Mutations not the only gene defect that leads to cancer
6. Mutation on Y chromosome stops sperm production
7. Mutation in PTEN gene can cause cancer and autoimmune disease
8. Emory University Scientists Demonstrate New Pathway For Genetic Mutations In Everyday Cell Life
9. Genetic Mutations Linked To Rare Metabolic Disease
10. Researchers Discover Genetic Mutation For Rare Form Of Dwarfism
11. Discovery Of Mutation May Lead To Help For Male Fertility Problems

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mutation may help cause acute myeloid leukemia

(Date:10/22/2014)... Medicine® scientists helps explain how bipolar disorder affects the ... therapies to treat the mental illness. , Scientists ... method recognized with the 2014 Nobel Prize in ... from mice with bipolar-like behaviors. In the synapses (where ... structures with concentrated levels of ANK3 -- the gene ...
(Date:10/22/2014)... , Oct. 20, 2014  Leading identity analyst firm ... half of the world,s population will have a chip-based ... Europe . Asia , ... market accounting for more than 60% of all National ... Acuity,s report  -- "The Global National eID ...
(Date:10/19/2014)... in India over the last 30 years contributed ... growth during that time, according to a new ... Change ., "Energy access is fundamental to development: ... including education, communication, and health," says IIASA researcher ... increased energy access is widely agreed to be ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Improved electricity access has little impact on climate change 2
(Date:10/25/2014)... , October 24, 2014 ... Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals Inc. ... ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... Thursday, October 23, 2014, ended on a positive note ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider of ... a team of researchers from Yale University’s School of ... to provide electronic questionnaire data collection through use of ... in May, aims to evaluate the impact of a ... and participation in urban agriculture to impact their consumption ...
(Date:10/22/2014)... ROCKVILLE, Md. , Oct. 22, 2014   ... company developing novel pathogen-specific therapies for serious infections and ... Office has issued a Notice of Allowance for a ... product in its C. difficile program, SYN-004. This ... to SYN-004 in the U.S. and adds to the ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
Cached News: